1. Home
  2. BLLN vs KNX Comparison

BLLN vs KNX Comparison

Compare BLLN & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$132.63

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Knight-Swift Transportation Holdings Inc.

KNX

Knight-Swift Transportation Holdings Inc.

HOLD

Current Price

$76.74

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
KNX
Founded
2016
1989
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
7.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
BLLN
KNX
Price
$132.63
$76.74
Analyst Decision
Buy
Strong Buy
Analyst Count
7
20
Target Price
$126.71
$65.00
AVG Volume (30 Days)
706.5K
3.5M
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
1.26%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,469,689,000.00
Revenue This Year
$46.29
$6.91
Revenue Next Year
$30.14
$7.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.80
52 Week Low
$61.96
$38.63
52 Week High
$138.70
$82.86

Technical Indicators

Market Signals
Indicator
BLLN
KNX
Relative Strength Index (RSI) 64.49 53.27
Support Level $79.07 $72.69
Resistance Level $138.70 $78.88
Average True Range (ATR) 7.07 2.41
MACD -0.17 -0.09
Stochastic Oscillator 92.55 64.79

Price Performance

Historical Comparison
BLLN
KNX

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: